Hepatitis C Virus (HCV) Evades NKG2D-Dependent NK Cell Responses through NS5A-Mediated Imbalance of Inflammatory Cytokines
Open accessThe DOI matches its Crossref record; 77 of the 78 references it cites were found in a registry or an index.
Abstract
Understanding how hepatitis C virus (HCV) induces and circumvents the host's natural killer (NK) cell-mediated immunity is of critical importance in efforts to design effective therapeutics. We report here the decreased expression of the NKG2D activating receptor as a novel strategy adopted by HCV to evade NK-cell mediated responses. We show that chronic HCV infection is associated with expression of ligands for NKG2D, the MHC class I-related Chain (MIC) molecules, on hepatocytes. However, NKG2D expression is downmodulated on circulating NK cells, and consequently NK cell-mediated cytotoxic capacity and interferon-γ production are impaired. Using an endotoxin-free recombinant NS5A protein, we show that NS5A stimulation of monocytes through Toll-like Receptor 4 (TLR4) promotes p38- and PI3 kinase-dependent IL-10 production, while inhibiting IL-12 production. In turn, IL-10 triggers secretion of TGFβ which downmodulates NKG2D expression on NK cells, leading to their impaired effector functions. Moreover, culture supernatants of HCV JFH1 replicating Huh-7.5.1 cells reproduce the effect of recombinant NS5A on NKG2D downmodulation. Exogenous IL-15 can antagonize the TGFβ effect and restore normal NKG2D expression on NK cells. We conclude that NKG2D-dependent NK cell functions are modulated during chronic HCV infection, and demonstrate that this alteration can be prevented by exogenous IL-15, which could represent a meaningful adjuvant for therapeutic intervention.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Figures




![Figure 5 NS5A induces IL-10 and suppresses IL-12 production by monocytes through TLR4-mediated activation of p38 and PI3 kinase signaling. A) Left panel: Control monocytes (0.1×106/ml) were cultured in medium alone, or in the presence of NS4 (0.5 µg/ml), NS5A (0.5 µg/ml), LPS (1 µg/ml), or NS5A+LPS for 24 hr, and cell supernatants were analyzed for IL-10 by ELISA. Data are expressed as the mean ± SEM of three independent experiments. * P = 0.01. Right panel: Monocytes were pretreated with IL-10 neutralizing mAb or soluble IL-10 receptor prior to stimulation with NS5A, and TGFβ levels in the culture supernatants were quantified by ELISA. Results are expressed as index of inhibition of NS5A-mediated TGFβ levels, calculated as: [(TGFβ (NS5A) - TGFβ (NS5A+mAb))/TGFβ (NS5A) - TGFβ (medium)]x100, and are the mean ± SEM of three independent experiments. * P = 0.02, ** P = 0.0005. B) For IL-12p70 production, monocytes were first primed by IFNγ for 16 h and then stimulated with LPS (1 µg/ml), HCV-NS5A (0.5 µg/ml) or both for 24 hr, after which supernatants were analyzed for IL-12 by ELISA. Data are expressed as the mean ± SEM of three independent experiments. * P = 0.02, ** P = 0.001. C) Purified monocytes were pretreated with 5 µg/ml of anti-TLR4, -TLR2 or -CD14 neutralizing antibodies prior to 24 hr stimulation with 0.5 µg/ml of NS5A, after which IL-10 levels in the supernatants were measured by ELISA. Results are the mean ± SEM of IL-10 levels from mean replica values in 3 independent experiments. * P = 0.02, ** P = 0.01. D) Binding of NS5A to monocytes. Control monocytes were incubated for 30 min at 4°C with 0.5 µg/ml of recombinant NS5A, NS4 or medium alone. Binding of NS5A to monocytes was revealed by staining with anti-NS5A 9E10 antibody and flow cytometry analysis. Results are expressed as the percentage of positive cells, and are the mean of 4 independent experiments. E) Monocytes were left untreated, or treated with JNK inhibitor (SP600125, 10 µM), MEK inhibitor (U0126, 10 µM), PI3K inhibitor (LY294002, 1–50 µM), p38 inhibitor (SB203580, 0.1–10 µM) or DMSO alone as negative control, for 1 hr prior to stimulation with NS5A (0.5 µg/ml) for additional 24 h. Supernatants were assayed for IL-10 content by ELISA. Results represent the percentage of inhibition of IL-10 production, and are the mean ± SEM of 3 separate experiments. * P<0.01.](https://figures.cochat.ai/paper-figures/88424d6dbca04d50953954fe9fa93795/hepatitis-c-virus-hcv-evades-nkg2d-dependent-nk-cell-responses-through-ns5a-figure-5.jpg)
![Figure 6 Supernatants of HCV-infected Huh-7.5.1 cells reproduce the effect of recombinant NS5A. A) Control PBMCs were cultured for 48 hr in medium alone, in medium containing 0.5 µg/ml of recombinant NS5A, or in medium containing 50% of supernatant from non-infected or JFH1-replicating Huh-7.5.1 cells (collected at day 3, 13, 15 or 18 post transfection). NKG2D expression on NK cells was analyzed 48 hr later by flow cytometry. * P<0.05, ** P = 10−4 for comparison with the values in medium alone. B) Control monocytes were incubated for 30 min at 4°C with supernatants from non-infected or JFH1-infected Huh-7.5.1 cells collected at the indicated day post infection, or with 0.5 µg/ml of recombinant NS4 or NS5A proteins as negative and positive controls, respectively. Binding of NS5A to monocytes was revealed by staining with anti-NS5A 9E10 antibody and flow cytometry analysis. Results are expressed as the index of binding ([% binding with culture supernatant - % binding with medium alone]/% binding with medium alone), and represent mean ± SEM of 2 independent experiments. C) NKG2D expression on liver-infiltrating NK cells from HCV patients. Left panel: Representative NKG2D staining in paired circulating and liver-infiltrating NK cells freshly isolated from one chronically infected HCV patient. Dot plots and corresponding histograms show the frequency of NK cells (boxed CD3-CD56+) and their NKG2D expression. Right panel: NKG2D staining with anti-NKG2D mAb in liver biopsy from a chronically HCV-infected patient. Results are representative of 4 HCV patients. Only few NKG2D-positive cells (arrows) are found within a mononuclear infiltrate surrounding a portal tract. Original magnification, ×40.](https://figures.cochat.ai/paper-figures/31286c58f8954a79b6a1c4412c7ded48/hepatitis-c-virus-hcv-evades-nkg2d-dependent-nk-cell-responses-through-ns5a-figure-6.jpg)

Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“In the liver, hepatic stress caused by hepatitis B and C virus infection was associated with the induction of ligands for the activating receptor NKG2D (18,19).”
From NKG2D-mediated detection of metabolically stressed hepatocytes by innate-like T cells is essential for initiation of NASH and fibrosis (2023) · cites this paper as [18]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Akira, S., & Takeda, K. (2004) · Nature reviews. Immunology · doi:10.1038/nri1391 · Cited by 8,312 · cited 1×
“TLR4 signaling results in the downstream activation of NF-kB, MAPK (p38 and JNK) and PI3K pathways [28].”
The HCV Life Cycle: In vitro Tissue Culture Systems and Therapeutic Targets
Gerold, G., & Pietschmann, T. (2014) · Digestive Diseases · doi:10.1159/000360830 · Cited by 4,854
Activation of NK Cells and T Cells by NKG2D, a Receptor for Stress-Inducible MICA
Bauer, S., Groh, V., Wu, J., Steinle, A., Phillips, J. H., Lanier, L. L., & Spies, T. (1999) · Science · doi:10.1126/science.285.5428.727 · Cited by 2,999 · cited 1×
“of NKG2D-positive NK cells in controls (60%) from Oliviero’s study, although NKG2D is usually reported to be constitutively expressed on all NK cells [12].”
Lanier, L. L. (2005) · Annual Review of Immunology · doi:10.1146/annurev.immunol.23.021704.115526 · Cited by 2,769 · cited 1×
“inhibitory and activating receptors [2].”
Production of infectious hepatitis C virus in tissue culture from a cloned viral genome
Wakita, T., Pietschmann, T., Kato, T., Date, T., Miyamoto, M., Zhao, Z., Murthy, K., Habermann, A., Kräusslich, H.-G., Mizokami, M., et al. (2005) · Nature Medicine · doi:10.1038/nm1268 · Cited by 2,754 · cited 3×
“1 hepatoma cells transfected or not with the infectious genotype 2a JHF1 replicon [34,35].”
Complete Replication of Hepatitis C Virus in Cell Culture
Lindenbach, B. D., Evans, M. J., Syder, A. J., Wölk, B., Tellinghuisen, T. L., Liu, C. C., Maruyama, T., Hynes, R. O., Burton, D. R., McKeating, J. A., et al. (2005) · Science · doi:10.1126/science.1114016 · Cited by 2,238 · cited 2×
“After washing and blocking with human IgG, cells were incubated for 40 min at 4°C with the mouse 9E10 mAb specific for genotype 2a NS5A (a generous gift from C.M. Rice, Rockefeller University, NY, USA) [74], followed with PE-labeled goat anti-mouse Ig, and analyzed by flow cytometry.”
Robust hepatitis C virus infection in vitro
Zhong, J., Gastaminza, P., Cheng, G., Kapadia, S., Kato, T., Burton, D. R., Wieland, S. F., Uprichard, S. L., Wakita, T., & Chisari, F. V. (2005) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0503596102 · Cited by 1,709 · cited 3×
“1 hepatoma cells transfected or not with the infectious genotype 2a JHF1 replicon [34,35].”
Tumour-derived soluble MIC ligands impair expression of NKG2D and T-cell activation
Groh, V., Wu, J., Yee, C., & Spies, T. (2002) · Nature · doi:10.1038/nature01112 · Cited by 1,592 · cited 2×
“Soluble TGFb is associated with NKG2D reduction Systemic NKG2D downregulation on immune effector cells has been related to the release of soluble factors such as MIC molecules (sMIC) in the serum of cancer patients [13].”
HLA and NK Cell Inhibitory Receptor Genes in Resolving Hepatitis C Virus Infection
Khakoo, S. I., Thio, C. L., Martin, M. P., Brooks, C. R., Gao, X., Astemborski, J., Cheng, J., Goedert, J. J., Vlahov, D., Hilgartner, M., et al. (2004) · Science · doi:10.1126/science.1097670 · Cited by 1,179 · cited 1×
“influence of genetic polymorphisms of KIR and their HLA ligands on the outcome of HCV infection [4].”
Costimulation of CD8αβ T cells by NKG2D via engagement by MIC induced on virus-infected cells
Groh, V., Rhinehart, R., Randolph-Habecker, J., Topp, M. S., Riddell, S. R., & Spies, T. (2001) · Nature Immunology · doi:10.1038/85321 · Cited by 951
Cited by
Living in the liver: hepatic infections
Protzer, U., Maini, M. K., & Knolle, P. A. (2012) · Nature Reviews Immunology · doi:10.1038/nri3169 · Cited by 560
Natural killer cells in antiviral immunity
Björkström, N. K., Strunz, B., & Ljunggren, H.-G. (2022) · Nature Reviews Immunology · doi:10.1038/s41577-021-00558-3 · Cited by 503
Pathogenesis of chronic viral hepatitis: differential roles of T cells and NK cells
Rehermann, B. (2013) · Nature Medicine · doi:10.1038/nm.3251 · Cited by 468
Innate and adaptive immune responses in HCV infections
Heim, M. H., & Thimme, R. (2014) · Journal of Hepatology · doi:10.1016/j.jhep.2014.06.035 · Cited by 305
“For example, a recent report suggests that NS5A-containing apoptotic bodies can trigger monocytes to produce increased amounts of IL-10 and decreased levels of IL-12 that leads to a significant downregulation of NKG2D on NK cells via TGF-b [103].”
BackgroundNatural killer cells in liver disease
Tian, Z., Chen, Y., & Gao, B. (2013) · Hepatology · doi:10.1002/hep.26115 · Cited by 290
“Suppression of intrahepatic NK cell functions may be the result of either cell-to-cell contact with HCVinfected hepatocytes(60) or TGF-b production from HCV protein-stimulated monocytes.(45) Further studies are required to clarify functions of intrahepatic NK cells during chronic HCV infection.”
BackgroundImmune tolerance in liver disease
Crispe, I. N. (2014) · Hepatology · doi:10.1002/hep.27254 · Cited by 275
“There is evidence both from the animal model of liver injury induced by concanavalin A, as well as from infection of KCs with yellow fever virus (YFV), that IL-10 acts to limit tissue injury.44,45 KCs also respond to TGFb1 on apoptotic cell fragments by secreting IL-10.”
BackgroundInfluentialSun, C., Fu, B., Gao, Y., Liao, X., Sun, R., Tian, Z., & Wei, H. (2012) · PLoS Pathogens · doi:10.1371/journal.ppat.1002594 · Cited by 202
Glässner, A., Eisenhardt, M., Krämer, B., Körner, C., Coenen, M., Sauerbruch, T., Spengler, U., & Nattermann, J. (2012) · Laboratory Investigation · doi:10.1038/labinvest.2012.54 · Cited by 167
Ahlenstiel, G., Edlich, B., Hogdal, L. J., Rotman, Y., Noureddin, M., Feld, J. J., Holz, L. E., Titerence, R. H., Liang, T. J., & Rehermann, B. (2011) · Gastroenterology · doi:10.1053/j.gastro.2011.06.069 · Cited by 149
Impairment of NKG2D-Mediated Tumor Immunity by TGF-β
Lazarova, M., & Steinle, A. (2019) · Frontiers in Immunology · doi:10.3389/fimmu.2019.02689 · Cited by 149
“TGF-β-mediated down-regulation of NKG2D and associated impaired NK cell functions were also reported in the context of infections with hepatitis B and C viruses (110, 111).”
BackgroundActivation of Natural Killer Cells during Microbial Infections
Horowitz, A., Stegmann, K. A., & Riley, E. M. (2012) · Frontiers in Immunology · doi:10.3389/fimmu.2011.00088 · Cited by 135
“The mechanism by which NK cells acquire this type of memory phenotype is an area of ongoing research but the fact that a similar phenotype is observed among NK cells primed by TLR-activated DCs and IL-15 (Lucas et al., 2007) or activated with a cocktail of cytokines (IL-12, IL-18, and IL-15; Cooper et al., 2009), that…”
BackgroundInfluentialFailure of innate and adaptive immune responses in controlling hepatitis C virus infection
Thimme, R., Binder, M., & Bartenschlager, R. F. W. (2011) · FEMS Microbiology Reviews · doi:10.1111/j.1574-6976.2011.00319.x · Cited by 149
Impaired intrahepatic natural killer cell cytotoxic function in chronic hepatitis C virus infection
Varchetta, S., Mele, D., Mantovani, S., Oliviero, B., Cremonesi, E., Ludovisi, S., Michelone, G., ALESSIANI, M., Rosati, R., Montorsi, M., et al. (2012) · Hepatology · doi:10.1002/hep.25723 · Cited by 109
“ALT, U/mL, median (range) 66 (9-716) 19 (11-45)”
Strunz, B., Hengst, J., Deterding, K., Manns, M. P., Cornberg, M., Ljunggren, H., Wedemeyer, H. H., & Björkström, N. K. (2018) · Nature Communications · doi:10.1038/s41467-018-04685-9 · Cited by 91
Natural Killer Cells in Viral Hepatitis
Rehermann, B. (2015) · Cellular and Molecular Gastroenterology and Hepatology · doi:10.1016/j.jcmgh.2015.09.004 · Cited by 92
Natural killer cells: multifaceted players with key roles in hepatitis C immunity
Golden‐Mason, L., & Rosen, H. R. (2013) · Immunological Reviews · doi:10.1111/imr.12090 · Cited by 96
“The suggested mechanism is that NS5A triggers IL-10 secretion from monocytes, which in turn promotes TGFb production, which leads to downmodulation of NKG2D expression and impaired effector functions both IFN-c and CD107a degranulation (97).”
BackgroundControl of NK Cell Activation by Immune Checkpoint Molecules
Beldi‐Ferchiou, A., & Caillat‐Zucman, S. (2017) · International Journal of Molecular Sciences · doi:10.3390/ijms18102129 · Cited by 86
Self-citationInflammatory status in human hepatic cirrhosis
Martinez‐Esparza, M., Tristán-Manzano, M., Ruiz-Alcaraz, A. J., & García-Peñarrubia, P. (2015) · World Journal of Gastroenterology · doi:10.3748/wjg.v21.i41.11522 · Cited by 87
Werner, J. M., Heller, T., Gordon, A. M., Sheets, A., Sherker, A. H., Kessler, E. R., Bean, K. S., Stevens, M., Schmitt, J. M., & Rehermann, B. (2013) · Hepatology · doi:10.1002/hep.26353 · Cited by 79
“NKG2C, for example, recognizes the nonclassical MHC I molecule HLA-E, the expression of which is altered in HCV infection,(9) and NKG2D recognizes MICA/B molecules, which are induced in HCV infection.(10) NK cell activation can also be mediated by inflammatory cytokines such as type I interferons and interleukin (IL)-…”
BackgroundLetafati, A., Ardekani, O. S., Naderisemiromi, M., Norouzi, M., Shafiei, M., Nik, S., & Mozhgani, S. (2024) · Virology Journal · doi:10.1186/s12985-024-02287-0 · Cited by 77
“The presence of IL-10 induces the secretion of TGF-β, which further decreases NKG2D expression on NK cells [82].”
BackgroundMantovani, S., Oliviero, B., Varchetta, S., Mele, D., & Mondelli, M. U. (2020) · Cancers · doi:10.3390/cancers12040926 · Cited by 71
“Also, in HCV-induced HCC, NS5A protein stimulates monocytes to produce the immunosuppressive cytokine interleukin-10 (IL-10) which can induce the release of TGF- resulting in impaired immune response [27].”
BackgroundDupuy, S., Lambert, M., Zucman, D., Choukem, S. P., Tognarelli, S., Pagès, C., Lebbé, C., & Caillat‐Zucman, S. (2012) · PLoS Pathogens · doi:10.1371/journal.ppat.1002486 · Cited by 67
Self-citationYoon, J. C., Lim, J., Park, J. H., & Lee, J. M. (2011) · Journal of Virology · doi:10.1128/jvi.00838-11 · Cited by 72
“tory cytokines, such as IL-10 and transforming growth factor (TGF- ), suppresses NK cell cytotoxicity (30), while chronic exposure to activating cytokine IFN- contributes to the polarization of NK cells toward cytotoxicity (1, 27).”
BackgroundInfluentialInteraction of Hepatitis C virus proteins with pattern recognition receptors
Imran, M., Waheed, Y., Manzoor, S., Bilal, M., Ashraf, W., Ali, M., & Ashraf, M. (2012) · Virology Journal · doi:10.1186/1743-422x-9-126 · Cited by 65
Chu, P., Nakamoto, N., Taniki, N., Ojiro, K., Amiya, T., Makita, Y., Murata, H., Yamaguchi, A., Shiba, S., Miyake, R., et al. (2017) · PLoS ONE · doi:10.1371/journal.pone.0179096 · Cited by 64
The Paradoxical Role of NKG2D in Cancer Immunity
Sheppard, S., Ferry, A., Guedes, J., & Guerra, N. (2018) · Frontiers in Immunology · doi:10.3389/fimmu.2018.01808 · Cited by 64
“During the course of HCV infection, MICA/B expression is elevated compared to healthy individuals (79) and HCV proteins were shown to enhance cell surface expression of ULBP-1 on human immortalized hepatocytes (117).”
BackgroundInfluentialCifaldi, L., Doria, M., Cotugno, N., Zicari, S., Cancrini, C., Palma, P., & Rossi, P. (2019) · International Journal of Molecular Sciences · doi:10.3390/ijms20153715 · Cited by 69
“This cytokine stimulates the secretion of transforming growth factor (TGF)-β and downregulates NKG2D on the NK cell surface [186], thus contrasting the immune-mediated viral clearance in the liver’s microenvironment.”
BackgroundKokordelis, P., Krämer, B., Körner, C., Boesecke, C., Voigt, E., Ingiliz, P., Glässner, A., Eisenhardt, M., Wolter, F., Kaczmarek, D., et al. (2014) · Hepatology · doi:10.1002/hep.26782 · Cited by 55
“AST U/L 493 (16-1,638) 348 (24-2,006) 49 (20-102) 20 (16-24) n.”
Pembroke, T., Christian, A. D., Jones, E., Hills, R. K., Wang, E. C. Y., Gallimore, A., & Godkin, A. J. (2013) · Gut · doi:10.1136/gutjnl-2013-304472 · Cited by 58
Natural killer cells in hepatitis C: Current progress
Yoon, J. C., Yang, C. M., Song, Y., & Lee, J. M. (2016) · World Journal of Gastroenterology · doi:10.3748/wjg.v22.i4.1449 · Cited by 67
Extrahepatic manifestations in chronic hepatitis C virus carriers
Rosenthal, É., & Cacoub, P. (2015) · Lupus · doi:10.1177/0961203314556140 · Cited by 62
Self-citationThe role of NK cells in fighting the virus infection and sepsis
Ma, L., Li, Q., Cai, S., Peng, H., Huyan, T., & Yang, H. (2021) · International Journal of Medical Sciences · doi:10.7150/ijms.59898 · Cited by 53
“For example, in chronic hepatitis virus infection, hepatitis C virus (HCV) downregulates NKG2D expression on circulating NK cells through an NS5A-mediated pathway and downregulates NKp30 expression by increasing the levels of an antagonistic NKp30 ligand on HCV-infected cells, which subsequently impairs NK cell-mediat…”
BackgroundMICA SNPs and the NKG2D system in virus-induced HCC
Goto, K., & Kato, N. (2014) · Journal of Gastroenterology · doi:10.1007/s00535-014-1000-9 · Cited by 53
Esteso, G., Luzón, E., Sarmiento, E., Gómez-Caro, R., Steinle, A., Murphy, G., Carbone, J., Valés‐Gómez, M., & Reyburn, H. T. (2014) · The Journal of Immunology · doi:10.4049/jimmunol.1303441 · Cited by 51
“However, immunosurveillance via NKG2D is also important in immunity to various viruses, including HIV (7, 8), HCV (9, 10), poxviruses (11), and human CMV (HCMV) (12, 13), that use diverse mechanisms to modulate the expression of the NKG2D receptor and its ligands.”
BackgroundDiversification of human NK cells: Lessons from deep profiling
Wilk, A. J., & Blish, C. A. (2018) · Journal of Leukocyte Biology · doi:10.1002/jlb.6ri0917-390r · Cited by 54
Zaki, M. Y. W., Fathi, A. M., Samir, S., Eldafashi, N., William, K. Y., Nazmy, M., Fathy, M., Gill, U. S., & Shetty, S. (2022) · Cancers · doi:10.3390/cancers14051255 · Cited by 54
Eisenhardt, M., Glässner, A., Krämer, B., Körner, C., Sibbing, B., Kokordelis, P., Nischalke, H. D., Sauerbruch, T., Spengler, U., & Nattermann, J. (2012) · PLoS ONE · doi:10.1371/journal.pone.0038846 · Cited by 44
Marinović, S., Lenartić, M., Mladenić, K., Šestan, M., Kavazović, I., Benić, A., Krapić, M., Rindlisbacher, L., Cokarić Brdovčak, M., Sparano, C., et al. (2023) · Science Immunology · doi:10.1126/sciimmunol.add1599 · Cited by 43
“In the liver, hepatic stress caused by hepatitis B and C virus infection was associated with the induction of ligands for the activating receptor NKG2D ( 17 , 18 ).”
BackgroundInnate immune cell networking in hepatitis C virus infection
Saha, B., & Szabó, G. (2014) · Journal of Leukocyte Biology · doi:10.1189/jlb.4mr0314-141r · Cited by 45
Wu, J., Zhang, X., Shi, K., Chen, Y., Ren, Y.-F., Song, Y., Li, G., Xue, Y.-F., Fang, Y., Deng, Z., et al. (2013) · Carcinogenesis · doi:10.1093/carcin/bgt268 · Cited by 44
“escape NKG2D immunity by down-regulation of NKG2D ligands [17-19].”
BackgroundPol, J. G., Lekbaby, B., Redelsperger, F., Klamer, S., Mandouri, Y., Ahodantin, J., Bièche, I., Lefèvre, M., Souque, P., Charneau, P., et al. (2015) · The FASEB Journal · doi:10.1096/fj.14-258715 · Cited by 43
Impact of natural killer cells on chronic hepatitis C and hepatocellular carcinoma
Tatsumi, T., & Takehara, T. (2015) · Hepatology Research · doi:10.1111/hepr.12619 · Cited by 42
Limited Hepatitis B Virus Replication Space in the Chronically Hepatitis C Virus-Infected Liver
Wieland, S. F., Asabe, S., Engle, R. E., Purcell, R. H., & Chisari, F. V. (2014) · Journal of Virology · doi:10.1128/jvi.03553-13 · Cited by 38
Crosstalk between NK cells and hepatic stellate cells in liver fibrosis (Review)
Zhang, Y., Wu, Y., Shen, W., Wang, B., & Yuan, X. (2022) · Molecular Medicine Reports · doi:10.3892/mmr.2022.12724 · Cited by 35
NK cell function and receptor diversity in the context of HCV infection
Gardiner, C. M. (2015) · Frontiers in Microbiology · doi:10.3389/fmicb.2015.01061 · Cited by 36
“Other studies have used a variety of control groups, e.g., healthy normal donors or non-infected IVDU patients to compare to chronic infection but this analysis is confounded by the fact that within the control group, some of the individuals would resolve and Frontiers in Microbiology |…”
BackgroundCytokines and serum amyloid A in the pathogenesis of hepatitis C virus infection
Salama, S. A., Lavie, M., Buck, M. D., Damme, J. V., & Struyf, S. (2019) · Cytokine & Growth Factor Reviews · doi:10.1016/j.cytogfr.2019.10.006 · Cited by 32
Carlomagno, S., Falco, M., Bono, M., Alicata, C., Garbarino, L., Mazzocco, M., Moretta, L., Moretta, A., & Sivori, S. (2017) · Frontiers in Immunology · doi:10.3389/fimmu.2017.00581 · Cited by 31
Immunomodulation of the Natural Killer Cell Phenotype and Response during HCV Infection
Njiomegnie, G. F., Read, S. A., Fewings, N., George, J., McKay, F. C., & Ahlenstiel, G. (2020) · Journal of Clinical Medicine · doi:10.3390/jcm9041030 · Cited by 32
Viral Evasion of Natural Killer Cell Activation
Ma, Y., Li, X., & Kuang, E. (2016) · Viruses · doi:10.3390/v8040095 · Cited by 31
Qu, M., Xu, Y., Liu, D., Ma, Y., Zhu, J., Cui, J., Yu, M., Li, C., & Guo, D. (2017) · Stem Cells and Development · doi:10.1089/scd.2016.0348 · Cited by 32
“T h e fi n al p u b li sh ed v er si o n m ay d if fe r fr o m t h is p ro o f. BM-MSC-derived TGF-β1 suppresses NKG2D expression on NK cells Previous studies have shown that soluble TGF-β1 is closely associated with the reduction in NKG2D during chronic HCV [18] and HBV infection [6].”
BackgroundInfluentialMody, C. H., Ogbomo, H., Xiang, R. F., Kyei, S. K., Feehan, D. D., Islam, A., & Li, S. S. (2019) · Journal of Leukocyte Biology · doi:10.1002/jlb.mr0718-298r · Cited by 32
Razizadeh, M. H., Zafarani, A., Taghavi-Farahabadi, M., Khorramdelazad, H., Minaeian, S., & Mahmoudi, M. (2023) · Cell Communication and Signaling · doi:10.1186/s12964-023-01266-2 · Cited by 33
“In turn, IL-10 decreases the NKG2D expression, leading to the impairments of NK cell anti-viral response [75].”
BackgroundFugier, E., Marche, H., Thelu, M. A., Jílková, Z. M., Campenhout, N. V., Dufeu‐Duchesne, T., Leroy, V., Zarski, J., Stürm, N., Marche, P. N., et al. (2014) · PLoS ONE · doi:10.1371/journal.pone.0095614 · Cited by 31
Self-citationControl of HCV Infection by Natural Killer Cells and Macrophages
Rosen, H. R., & Golden‐Mason, L. (2019) · Cold Spring Harbor Perspectives in Medicine · doi:10.1101/cshperspect.a037101 · Cited by 32
“There is impairment of MICA/B expression in HCV infection, which may result in lower levels of NK cell activation via the NKG2D receptor (Jinushi et al. 2003; Wen et al. 2008; Sene et al. 2010).”
BackgroundInfluentialEyre, N. S., Aloia, A. L., Joyce, M., Chulanetra, M., Tyrrell, D. L., & Beard, M. R. (2017) · Virology · doi:10.1016/j.virol.2017.04.003 · Cited by 27
NK Cells Prevalence, Subsets and Function in Viral Hepatitis C
Zeromski, J., Mozer‐Lisewska, I., Kaczmarek, M., Kowala-Piaskowska, A. E., & Sikora, J. (2011) · Archivum Immunologiae et Therapiae Experimentalis · doi:10.1007/s00005-011-0145-y · Cited by 27
“TGF-b decreases expression NKG2D on NK cells, and this results in impaired effector activity (Séne et al. 2010).”
BackgroundThe Natural Killer Cell Response to HCV Infection
Ahlenstiel, G. (2013) · Immune Network · doi:10.4110/in.2013.13.5.168 · Cited by 25
“and playing an important role in direct cytotoxicity (32).”
BackgroundAshraf, W., Manzoor, S., Ashraf, J., Ahmed, Q. L., Khalid, M., Tariq, M., Imran, M., & Aziz, H. (2013) · Viral Immunology · doi:10.1089/vim.2013.0044 · Cited by 25
Hepatitis C Virus Impairs Natural Killer Cell-Mediated Augmentation of Complement Synthesis
Kim, H., Bose, S. K., Meyer, K., & Ray, R. (2013) · Journal of Virology · doi:10.1128/jvi.02988-13 · Cited by 28
“NKG2D expression is lowered on circulating NK cells from patients with chronic hepatitis C (32).”
BackgroundRasmussen, A. L., Tchitchek, N., Susnow, N. J., Krasnoselsky, A. L., Diamond, D. L., Yeh, M. M., Proll, S. C., Korth, M. J., Walters, K., Lederer, S., et al. (2012) · Hepatology · doi:10.1002/hep.25612 · Cited by 23
Franzoni, G., Edwards, J. C., Kurkure, N. V., Edgar, D. S., Sánchez-Cordón, P. J., Haines, F. J., Salguero, F. J., Everett, H., Bodman-Smith, K. B., Crooke, H., et al. (2014) · Clinical and Vaccine Immunology · doi:10.1128/cvi.00382-14 · Cited by 23
Strategies to Circumvent Host Innate Immune Response by Hepatitis C Virus
Patra, T., Ray, R. B., & Ray, R. (2019) · Cells · doi:10.3390/cells8030274 · Cited by 24
“HCV NS5A protein stimulates monocytes through TLR-4 and induces secretion of IL-10, which subsequently stimulates the secretion of transforming growth factor (TGF)-β and downregulates NKG2D on the NK cell surface, resulting in functional impairment of NK cells [82].”
BackgroundConvergent Evolution by Cancer and Viruses in Evading the NKG2D Immune Response
Baugh, R. T., Khalique, H., & Seymour, L. W. (2020) · Cancers · doi:10.3390/cancers12123827 · Cited by 29
“NS5a Stimulates immunosuppressive cytokine production and NKG2D receptor downregulation [96]”
BackgroundJiang, H.-J., Wang, X., Luo, B.-F., Xu, C., Jin, Q., Qin, H., Zhang, H.-Y., Kong, X., Wei, L., & Feng, B. (2019) · Clinical and Experimental Medicine · doi:10.1007/s10238-019-00564-9 · Cited by 19
Immunopathogenesis of Hepatitis C Virus Infection
Kaplan, D. E. (2015) · Gastroenterology Clinics of North America · doi:10.1016/j.gtc.2015.07.004 · Cited by 21
“Monocyte-derived IL-10- and TGFβ also downregulate NK cell expression of the NKG2D receptor that might reduce NK cell sensitivity to MICA and MICB on infected hepatocytes (125, 126).”
BackgroundKondo, Y., Ueno, Y., & Shimosegawa, T. (2011) · Hepatitis Research and Treatment · doi:10.1155/2011/713216 · Cited by 17
“Many groups have described that NK and NK-T cells were suppressed in CHC patients [46–53].”
BackgroundPolo, M. L., Ghiglione, Y., Salido, J., Urioste, A., Poblete, G., Sisto, A. E., Martinez, A., Rolón, M. J., Ojeda, D. S., Cahn, P. E., et al. (2019) · Journal of the International AIDS Society · doi:10.1002/jia2.25375 · Cited by 18
“Together, our results are consistent with those reporting impaired functionality of NK cells during HCV monoinfection [32-36], and also HIV/HCV coinfection [29].”
ResultCellular and molecular mechanisms of hepatic fibrogenesis leading to liver cancer
Minicis, S. D., Marzioni, M., Saccomanno, S., Rychlicki, C., Agostinelli, L., Trozzi, L., Benedetti, A., & Svegliati‐Baroni, G. (2011) · Translational gastrointestinal cancer · Cited by 20
Nie, Y., Liu, D., Yang, W., Li, Y., Zhang, L., Cheng, X., Chen, R., Yuan, B., Zhang, G., & Wang, H. (2022) · Virology Journal · doi:10.1186/s12985-022-01776-4 · Cited by 16
“Additionally, it was found that the expression of KLRG1 increased in chronic hepatitis C [50].”
BackgroundContradicting roles of miR-182 in both NK cells and their host target hepatocytes in HCV
Sobky, S. A. E., El-Ekiaby, N. M., Mekky, R. Y., Elemam, N. M., ELZAHRY, M. A. M. E., Elsayed, M., Esmat, G., & Abdelaziz, A. I. (2015) · Immunology Letters · doi:10.1016/j.imlet.2015.10.013 · Cited by 17
Hepatitis C virus impairs natural killer cell activity via viral serine protease NS3
Yang, C. M., Yoon, J. C., Park, J. H., & Lee, J. M. (2017) · PLoS ONE · doi:10.1371/journal.pone.0175793 · Cited by 16
Quarleri, J. F., & Oubiña, J. R. (2015) · Annals of Hepatology · doi:10.5604/16652681.1184193 · Cited by 13
Vahedi, F., Lee, A. J., Collins, S. E., Chew, M. V., Lusty, E., Chen, B., Dubey, A., Richards, C. D., Feld, J. J., Russell, R. S., et al. (2018) · Cytokine · doi:10.1016/j.cyto.2018.06.006 · Cited by 16
Toll-like receptors and hepatitis C virus infection
Gao, Y., Nepal, N., & Jin, S. (2021) · Hepatobiliary & pancreatic diseases international · doi:10.1016/j.hbpd.2021.07.011 · Cited by 14
Structure and Molecular Virology
McGarvey, M. J., & Houghton, M. (2013) · Wiley eBooks · doi:10.1002/9781118637272.ch16 · Cited by 12
Mononuclear phagocyte system in hepatitis C virus infection
Yang, Y., Tu, Z., Liu, X.-K., & Zhang, P. (2018) · World Journal of Gastroenterology · doi:10.3748/wjg.v24.i44.4962 · Cited by 12
Elemam, N. M., Mekky, R. Y., El-Ekiaby, N. M., Sobky, S. A. E., Din, M. A. M. E., Esmat, G., & Abdelaziz, A. I. (2015) · Human Immunology · doi:10.1016/j.humimm.2015.09.021 · Cited by 11
Redwan, E. M. M. M., Aljaddawi, A. A., & Uversky, V. N. (2022) · Biology · doi:10.3390/biology11071091 · Cited by 11
Suda, T., Tatsumi, T., Nishio, A., Kegasawa, T., Yoshioka, T., Yamada, R., Furuta, K., Kodama, T., Shigekawa, M., Hikita, H., et al. (2018) · Hepatology Communications · doi:10.1002/hep4.1240 · Cited by 11
Harfouch, S., Guiguet, M., Valantin, M., Samri, A., Ouazene, Z., Slama, L., Dominguez, S., Simon, A., Theodorou, I. D., Thibault, V., et al. (2012) · Journal of Hepatology · doi:10.1016/j.jhep.2012.01.021 · Cited by 10
“Moreover, HCV/NS5A also induces monocytes to produce TGF-b, thus inhibiting NK cell effector functions [27].”
BackgroundRole natural killer group 2D-ligand interactions in hepatitis B infection
Pollicino, T., & Koumbi, L. (2015) · World Journal of Hepatology · doi:10.4254/wjh.v7.i6.819 · Cited by 10
Patel, S. S., Rybicki, L. A., Yurch, M. A., Thomas, D., Liu, H. D., Dean, R. M., Jagadeesh, D., Hill, B. T., Pohlman, B. L., Bolwell, B. J., et al. (2019) · Hematology/Oncology and Stem Cell Therapy · doi:10.1016/j.hemonc.2019.10.001 · Cited by 9
Hassouna, M. M., Radwan, E. M., Abdelsameea, E., Estaphan, S., Elrhman, H. E. A., Abdel-Samiee, M., & Naguib, M. A. (2021) · Asian Pacific Journal of Cancer Prevention · doi:10.31557/apjcp.2021.22.8.2559 · Cited by 8
NKG2D and its ligands: Key to immunotherapy of liver cancer?
Mondelli, M. U. (2011) · Journal of Hepatology · doi:10.1016/j.jhep.2011.07.008 · Cited by 8
The role of liver macrophages in viral liver pathogenesis
Brantly, A., Yeakle, K., Bouchard, M. J., Gaskill, P. J., & Nonnemacher, M. R. (2025) · Journal of Leukocyte Biology · doi:10.1093/jleuko/qiaf088 · Cited by 7
“145 NS5A can also upregulate NF-κ B and STAT-3 activation via induction of ROS and upregulation of Ca 2+ signaling, increasing inflammation, 218 as well as inhibiting protein kinase R (PKR) dimerization and subsequent PKR-mediated eukaryotic initiation factor-2a phosphorylation in HCV-infected…”
The Role of Natural Killer Cells in Hepatitis C Infection
Howell, J. A., & Visvanathan, K. (2013) · Antiviral Therapy · doi:10.3851/imp2565 · Cited by 10
“The HCV NS5A protein can stimulate monocytes via TLR4 to produce IL-10 and inhibits IL-12 production, with subsequent downstream impairment of NK cell NKG2D expression and function [100].”
BackgroundAsadi‐Saghandi, A., Shams, A., Eslami, G., Mirghanizadeh, S. A., & Eskandari‐Nasab, E. (2016) · VirusDisease · doi:10.1007/s13337-016-0349-1 · Cited by 7
Kochlios, E., Foka, P., & Mavromara, P. (2012) · Cited by 6
Arai, J., Okumura, A., Kato, N., & Ito, K. (2024) · Hepatology Research · doi:10.1111/hepr.14038 · Cited by 6
“19 Meanwhile, the HCV protease NS3/4A decreases the expression of NKG2D ligands, including MICA, resulting in escape from NK cell effector functions.”
BackgroundZientarska, A., Witkowska, A., Rozpłochowski, B., Mikuła‐Pietrasik, J., Kaczmarek, M., Kowala-Piaskowska, A. E., Książek, K., Zeromski, J., & Mozer‐Lisewska, I. (2021) · Central European Journal of Immunology · doi:10.5114/ceji.2021.109846 · Cited by 6
“482 is distorted; nevertheless, authors have reported various results of their studies [5-17].”
Giuliani, E., Vassena, L., Cerboni, C., & Doria, M. (2015) · Current Drug Targets · doi:10.2174/1389450116666150630110329 · Cited by 5
“Increased NKG2DLs expression has been reported in human cells infected with HIV-1 and several other viruses, including human cytomegalovirus (HCMV), adenovirus, Epstein-Barr virus (EBV), hepatitis C virus (HCV), vesicular stomatitis virus (VSV), measles virus (MV), respiratory syncytial virus (RSV), and influenza viru…”
BackgroundAfter the Storm: Persistent Molecular Alterations Following HCV Cure
Seurre, C., Suarez, A. A. R., Testoni, B., Zoulim, F., & Grigorov, B. (2024) · International Journal of Molecular Sciences · doi:10.3390/ijms25137073 · Cited by 7
Viral inhibitors of NKG2D ligands for tumor surveillance
Chávez-Blanco, A. D., Chacón‐Salinas, R., Domínguez-Gómez, G., González‐Fierro, A., Pérez‐Cárdenas, E., Taja‐Chayeb, L., Trejo‐Becerril, C., & Dueñas‐González, A. (2016) · Expert Opinion on Therapeutic Targets · doi:10.1080/14728222.2016.1202928 · Cited by 5
“on NK cells by inducing the production of TGF-b by target cells, impairing effector functions [43].”
BackgroundHow to get away with liver innate immunity? A viruses’ tale
Delphin, M., Desmares, M., Schuehle, S., Heikenwälder, M. F., Durantel, D., & Faure‐Dupuy, S. (2021) · Liver International · doi:10.1111/liv.15054 · Cited by 6
Khetsuphan, T., Chaisri, U., Dechkhajorn, W., Benjathummarak, S., Dekumyoy, P., Ampawong, S., Viriyavejakul, P., & Maneerat, Y. (2020) · Parasitology Research · doi:10.1007/s00436-019-06593-3 · Cited by 4
Haplotype analysis finds linkage disequilibrium in the IL-12 gene in patients with HCV
Houldsworth, A., Metzner, M., Hodgkinson, A., Shaw, S. R., Kaminski, E., Demaine, A. G., & Cramp, M. (2015) · Journal of Medical Virology · doi:10.1002/jmv.24179 · Cited by 4
“The cytokine interleukin-12 (IL-12) mediates a variety of these responses from resting lymphocytes, cytolytic T-cell maturation and cell stimulation [Trinchieri, 1995; Sene et al., 2010].”
BackgroundRagab, D., Samaha, D. Y., Mohamed, N. A., Rafik, M. M., & Abdelhady, W. (2020) · Microbiology and Immunology · doi:10.1111/1348-0421.12858 · Cited by 3
Liver Macrophages in the Pathogenesis of Viral Hepatitis
Tsomidis, I., Tsakou, A., Voumvouraki, A., & Kouroumalis, E. (2026) · Current Issues in Molecular Biology · doi:10.3390/cimb48070687 · Cited by 2
“[273,274] OR NS5A Pro-inflammatory Bind to TLR2.”
Obaid, A., Naz, A., Ashraf, S. T., Awan, F. M., Ikram, A., Saeed, M. T., Raza, A., Ahmad, J., & Ali, A. (2018) · Lecture notes in computer science · doi:10.1007/978-3-319-95171-3_50 · Cited by 2
“151 HCV, in turn also augments IL-10, and inhibits NK cells and IL-12 which results in the 152 activation of Tregs (Aste-Amezaga et al. 1998; Blackburn & Wherry 2007; Fiorentino et al. 153 1991; Hu et al. 2006; Sene et al. 2010).”
BackgroundMania, A., Kaczmarek, M., Kemnitz, P., Mazur‐Melewska, K., Figlerowicz, M., Sikora, J., Służewski, W., & Zeromski, J. (2017) · Medical Microbiology and Immunology · doi:10.1007/s00430-017-0526-x · Cited by 2
“describe decreased expression of the NKG2D activating receptor on NK cells as HCV strategy to evade natural immune response mechanisms, since NK cell-mediated cytotoxic capacity and interferon-γ production are impaired as a consequence [21].”
Background
Metadata
- Authors
- Sène, D., Levasseur, F., Abel, M., Lambert, M., Camous, X., Hernandez, C., Pène, V., Rosenberg, A. R., Jouvin-Marche, E., Marche, P. N., Cacoub, P., & Caillat-Zucman, S.
- Affiliations
- Inserm (FR)
- Université Paris Descartes (FR)
- Assistance Publique – Hôpitaux de Paris (FR)
- ORCID
- Venue
- PLoS Pathogens
- Publisher
- Public Library of Science (PLoS)
- Published
- 2010-11-11
- Volume
- 6
- Issue
- 11
- Pages
- e1001184
- ISSN
- 1553-7366 (ISSN-L)
- 1553-7374
- PMC
- PMC2978723
- OpenAlex
- W1968304159
- Cited by
- 113
- References
- 78
- Citations by year
- 2026: 1 · 2025: 1 · 2024: 3 · 2023: 2 · 2022: 4 · 2021: 7 · 2020: 5 · 2019: 11 · 2018: 8 · 2017: 11 · 2016: 5 · 2015: 14 · 2014: 10 · 2013: 11 · 2012: 12
- FWCI
- 4.25
- Type
- journal article
- Language
- en
- Open access
- gold
- doi.org
- Locations
- PLoS Pathogens (publishedVersion, cc-by)
- PubMed Central (publishedVersion, cc-by)
- PubMed (publishedVersion)
- HAL (submittedVersion, other-oa)
- DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
- Figshare (submittedVersion, cc-by)
- Funders
- Institut National de la Santé et de la Recherche Médicale
- Topics
- Life Sciences › Immunology and Microbiology › Immunology › Immune Cell Function and Interaction
- Health Sciences › Medicine › Hepatology › Hepatitis C virus research
- Life Sciences › Immunology and Microbiology › Immunology › interferon and immune responses
- Keywords
- hepatitis C virus, NKG2D, natural killer cells, NS5A, immune evasion, IL-10, IL-12, TGF-beta, IL-15, TLR4, p38 MAPK, PI3-kinase, interferon-gamma, chronic hepatitis C, hepatocytes
- MeSH terms
- Adult, Aged, Cytotoxicity, Immunologic, Female, Flow Cytometry, Humans, Immunity, Cellular, Killer Cells, Natural, Liver Cirrhosis, Male, Middle Aged, Monocytes, RNA-Dependent RNA Polymerase, Virus Replication, Hepacivirus, Cytokines, Viral Nonstructural Proteins, Inflammation Mediators, Hepatitis C, Chronic, NK Cell Lectin-Like Receptor Subfamily K, Young Adult
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.